Švicarska -
talijanski -
Swissmedic (Swiss Agency for Therapeutic Products)
monofer 1000 mg / 10 ml soluzione per via endovenosa/infusione
pierre fabre pharma sa - ferro(iii) - soluzione per via endovenosa/infusione - ferrum(iii) 1000 mg ut ferricum derisomaltosum, acidum hydrochloridum q.s. ad ph, natrii hydroxidum q.s. ad ph, aqua ad iniectabile q.s. ad solutionem pro 10 ml corresp. natrium max. 114 mg. - di comprovata carenza di ferro, se orale, integratori di ferro non sono efficaci o non possono essere applicate. - synthetika
Europska Unija -
talijanski -
EMA (European Medicines Agency)
impulsor
pierre fabre medicament - milnacipran - fibromialgia
Švicarska -
talijanski -
Swissmedic (Swiss Agency for Therapeutic Products)
braftovi 50 mg capsule rigide
pierre fabre pharma sa - encorafenibum - capsule rigide - encorafenibum 50 mg, excipiens pro capsula. - melanom mit braf-v600-mutation in kombination mit binimetinib,; metastasiertes kolorektalkarzinom (crc) mit einer braf-v600e-mutation in kombination mit cetuximab - synthetika
Švicarska -
talijanski -
Swissmedic (Swiss Agency for Therapeutic Products)
braftovi 75 mg capsule rigide
pierre fabre pharma sa - encorafenibum - capsule rigide - encorafenibum 75 mg, excipiens pro capsula. - melanom mit braf-v600-mutation in kombination mit binimetinib,; metastasiertes kolorektalkarzinom (crc) mit einer braf-v600e-mutation in kombination mit cetuximab - synthetika
Švicarska -
talijanski -
Swissmedic (Swiss Agency for Therapeutic Products)
mektovi 15 mg compresse rivestite con film
pierre fabre pharma sa - binimetinibum - compresse rivestite con film - binimetinibum 15 mg, excipiens pro compresso obducto. - melanoma con braf-v600-mutazione in combinazione con encorafenib - synthetika
Švicarska -
talijanski -
Swissmedic (Swiss Agency for Therapeutic Products)
nerlynx 40 mg compresse rivestite con film
pierre fabre pharma sa - neratinibum - compresse rivestite con film - neratinibum 40 mg a neratinibi malea, excipiens pro compresso haze. - brustkrebs - synthetika
Švicarska -
talijanski -
Swissmedic (Swiss Agency for Therapeutic Products)
alopexy 5% soluzione per l'applicazione sulla pelle
pierre fabre pharma sa - minoxidilum - soluzione per l'applicazione sulla pelle - minoxidilum 5 g, propylenglycolum 24 g, ethanolum 96 per centum 52 g, aqua purificata q.s. ad solutionem pro 100 ml. - alopecia androgenetica - synthetika
Europska Unija -
talijanski -
EMA (European Medicines Agency)
ebvallo
pierre fabre medicament - tabelecleucel - lymphoproliferative disorders - ebvallo is indicated as monotherapy for treatment of adult and paediatric patients 2 years of age and older with relapsed or refractory epstein-barr virus positive post-transplant lymphoproliferative disease (ebv+ ptld) who have received at least one prior therapy. for solid organ transplant patients, prior therapy includes chemotherapy unless chemotherapy is inappropriate.
